Article Versions Notes

Laoharawee K, Johnson MJ, Lahr WS, Sipe CJ, Kleinboehl E, Peterson JJ, Lonetree C-l, Bell JB, Slipek NJ, Crane AT, et al. A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes. International Journal of Molecular Sciences. 2022; 23(17):9749. https://doi.org/10.3390/ijms23179749

Laoharawee, Kanut, Matthew J. Johnson, Walker S. Lahr, Christopher J. Sipe, Evan Kleinboehl, Joseph J. Peterson, Cara-lin Lonetree, Jason B. Bell, Nicholas J. Slipek, Andrew T. Crane, and et al. 2022. "A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes" International Journal of Molecular Sciences 23, no. 17: 9749. https://doi.org/10.3390/ijms23179749

Laoharawee, K., Johnson, M. J., Lahr, W. S., Sipe, C. J., Kleinboehl, E., Peterson, J. J., Lonetree, C.-l., Bell, J. B., Slipek, N. J., Crane, A. T., Webber, B. R., & Moriarity, B. S. (2022). A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes. International Journal of Molecular Sciences, 23(17), 9749. https://doi.org/10.3390/ijms23179749